Abstract:Purpose: Pulmonary inflammatory pseudotumor (PIP) is an inflammatory proliferative tumor-like lesion that frequently exhibits hypermetabolism on 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography imaging (PET/CT) and is readily misdiagnosed as a malignant tumor. The purpose of this study was to identify PIP by combining PET/computed tomography metabolic and blood test characteristics with machine learning. Patients and Methods: We recruited 27 patients with PIP and 28 patients with lung cancer (LC). The PET metabolic and blood test parameters were collected, and the differences between the groups were evaluated. In addition, we combined the support vector machine (SVM) classifier with the indicators that differed between the groups to classify PIP and LC. Results: For PET metabolic parameters, our findings showed that, as compared with the LC group, maximal standardized uptake value ( P < 0.001, t = −4.780), Mean standardized uptake value SUV mean , P < 0.001, t = −4.946), and SD40% ( P < 0.001, t = −4.893) were considerably reduced in the PIP group, whereas CV40% ( P = 0.004, t = 3.012) was significantly greater. For blood test parameters, the total white blood cell count ( P < 0.001, t = 6.457) and absolute neutrophil count ( P < 0.001, t = 6.992) were substantially higher in the PIP group than in the LC group. Furthermore, the performance of SVM trained solely on PET metabolic parameters (mean area under the curve [AUC] = 0.84) was comparable to that of SVM trained solely on blood test parameters (mean AUC = 0.86). Surprisingly, utilizing the combined parameters increased SVM performance significantly (mean AUC = 0.98). Conclusion: PET metabolic and blood test parameters differed significantly between the PIP and LC groups, and the SVM paradigm using these significantly different features has the potential to be used to classify PIP and LC, which has important clinical implications.

The diagnosis and surgical treatment of imflammatory pseudotumor of lung

Diagnosis and Treatment of Pulmonary Inflammatory Pseudotumor

Report of 41 Cases with Inflammatory Pseudotumor of the Lung

CT Appearances of Pulmonary Inflammatory Pseudotumor and Pripheral Lung Cancer

A case of pulmonary inflammatory myofibroblastic tumor treated with bronchoscopic therapy plus lobectomy

Misdiagnosis analysis of pulmonary inflammatory pseudotumor

Advance in diagnosis and treatment of pulmonary lymphangitic carcinomatosis

The experience of Medicine Therapy in 48 cases with Pulmonary Inflammatory Pseudotumor

Diagnostic Performance of 18F-FDG Positron Emission Tomography/Computed Tomography and Blood Test Parameters for Pulmonary Inflammatory Pseudotumor

Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor–a retrospective study of 8 cases

Elevated 68 Ga-FAPI Activity in Pulmonary Inflammatory Pseudotumor

Pulmonary Nodular Lymphoid Hyperplasia: a Rare Benign Disease with Malignant Mask.

Inflammatory Myofibroblastic Tumor of the Lung: Correlation of CT Imaging Features and Pathology

[Diagnosis and therapeutics of 24 cases of pulmonary sclerosing hemangioma]

Case report: inflammatory pseudotumor in the lung parenchyma caused by a medical suture originating from a cardiac surgery 35 years ago

Differential diagnosis of localized pneumonic-type lung adenocarcinoma and pulmonary inflammatory lesion

Inflammatory Pseudotumor of the Thymus: A Case Report and Review of the Literature

Pneumonic-type invasive mucinous adenocarcinoma and infectious pneumonia: clinical and CT imaging analysis from multiple centers

Inflammatory Pseudotumor of the Liver or Intrahepatic Cholangiocarcinoma, That's the Question: A Review of the Literature

Pulmonary actinomycosis diagnosed by transbronchoscopic lung biopsy: A case report and literature review

Diagnosis and Treatment for Pulmonary Sclerosing Hemangioma